Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
Natasha Jolakoski, Clinical Pharmacy Specialist in Thrombosis and Hemostasis Management, shared a post on LinkedIn:
“I am excited to announce the completion of my PGY2 Residency in Thrombosis and Hemostasis Management at the University of New Mexico Hospital!
I am incredibly grateful to my preceptors, co-residents, colleagues, friends, and family for their guidance, encouragement, and unwavering support throughout this journey.
I truly would not be where I am today without each of you.
I am also excited to share that I will be joining UT Southwestern Medical Center as a Clinical Pharmacy Specialist in Thrombosis and Hemostasis Management. I look forward to this next chapter, continuing to grow as a clinician and embracing my role as a Thrombassador.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 16:04Jackie Kunzler: Accelerating Innovation in Blood Processing
-
Aug 13, 2026, 16:02Pablo Corral: Is Inflammation Really a Therapeutic Target in Atherosclerosis
-
Aug 13, 2026, 15:47Breck Gamel: Why Factor V Leiden Matters
-
Aug 13, 2026, 15:25Douglas Tavares: Clinical Strategies to Reduce Blood Transfusion and Donor Reliance
-
Aug 13, 2026, 15:21Naghmeh N.: Freeze Dried Plasma Could Transform Emergency Trauma Care
-
Aug 13, 2026, 15:20W. Alberto Sifuentes Giraldo: Targeting the JAK-STAT Pathway in Behçet’s Disease
-
Aug 13, 2026, 14:59Amber Paratore Sanchez: Glomerular Indications for Plasma Exchange and Represent UCSD
-
Aug 13, 2026, 14:52Thomas Dayspring: The Best Lipid Panel Surrogate of ApoB Concentration
-
Aug 13, 2026, 14:43Antoinette Gawin: Turning Innovation Into Action for America’s Blood Supply